期刊文献+

灯盏花素在正常和模型大鼠中的药代动力学及代谢物研究 被引量:19

Pharmacokinetics and metabolites of scutellarin in normal and model rats
下载PDF
导出
摘要 目的研究灯盏花素在正常和角叉菜胶致血栓形成大鼠中的药代动力学,并对其血浆样品中主要代谢物进行初步鉴定.方法RP-HPLC法测定静注36 mg·kg-1灯盏花素后正常和模型大鼠不同时间血浆样品中灯盏乙素浓度,3P97软件拟合房室模型,计算药动学参数;HPLC-PDA(光电二极管阵列)、LC-MS/MS技术分析鉴定血浆样品中的主要色谱峰.结果血浆中灯盏乙素在0.625~80.0μg·mL-1(r=0.999 5)线性关系良好,最低定量浓度:0.312μg·mL-1;正常和角叉菜胶致血栓形成状态下,灯盏乙素药时曲线均呈现二室开放模型.血浆样品中4个主要色谱峰的可能结构分别为4',5-二羟基黄酮-7-氧-β-D-葡糖醛酸甲酯苷(M1)、灯盏乙素(M2)、7-甲氧基-4',5-二羟基-黄酮(M3)和7-甲氧基-4',5,6-三羟基-黄酮(M4).结论正常和模型大鼠体内灯盏乙素的药动学参数有显著性差异;灯盏乙素在大鼠血浆样品中的代谢主要是脱羟基和甲基化途径. Aim To investigate the pharmaeokineties and metabolites of scutellarin in normal rats and rats with thronlbosis model induced by earrageenan. Methods Scutellarin was assayed by reverse phase high performance liquid ebromalography in various plasma samples after a single dose of 36 mg· kg^-1 iv to each rat, the pharmaeokinetie parameters were estimated by 3P97 program. The metabolites of seutellarin in blood 2ere ehromatographed and identified by HPLC-PDA, LC/MS/MS. Results The calibration curve was linear over the range fiom 0. 625 to 80. 0 μg· mL^-1 (r =0. 999 5 ) , the limit quantitation was 0. 312 μg· mL^-1. The plasma seutellarin eoneemration-time curve was fitted to the open two-compartment model. In the plasma samples, the main metabolites were deduced as 4',5-dihydroxyflavonon-7-O-β-D-glucuronopyranosyl ester ( M 1 ), scutellarin ( M2 ), 7-methoxy-4' ,5-dihydroxy-flavonon ( M3 ) and 7-methoxy-4' ,5,6-dihydroxy- flavonon (M4). Conclusion The phammeokinetic parameters of scutellarin were significantly different in normal and model rats. The metabolic pathways of seutellarin was proposed to be dehydroxylation and methylation.
出处 《药学学报》 CAS CSCD 北大核心 2005年第11期1024-1027,共4页 Acta Pharmaceutica Sinica
关键词 灯盏乙素 药代动力学 代谢物 scutellarin pharmacokinetics metaboliie
  • 相关文献

参考文献4

二级参考文献17

  • 1胡三觉,田巧莲,顾建文,沙建慧,赵德化,晏培松,朱新生,裴其应.一种新的体内血栓形成动物模型[J].第四军医大学学报,1993,14(1):69-69. 被引量:11
  • 2张人伟 杨生元 等.灯盏花的化学成分研究[J].药学学报,1981,16(1):68-68.
  • 3王锦平 王永铭.灯盏花药理作用的研究[J].中成药研究,1985,7(12):25-25.
  • 4[1]Chen XQ, Jin YY. The New Edition of Medicaments (新编药物学) [M]. 14th Ed. Beijing: People's Medical Publishing House, 1997.277-278.
  • 5[2]Xu QY, Li XX. Influences of Dengzhan Xixin injection on blood viscosity in patients with high blood viscosity [J]. Chin J New Drugs Clin Rem(中国新药与临床杂志), 1995,14(4):233-235.
  • 6[3]Xu JM, Huang ZH. DengZhan XiXin capsules in the treatment of cerebrovascular disorders in 74 patients [J]. Chin J New Drugs Clin Rem(中国新药与临床杂志), 1991,10(5):260-263.
  • 7[4]Department of Chinese Tradititional Medicine and Herbal Drugs, State Drug Administration. Handbook of Active Ingredients of Phytomedicines (植物药有效成分手册) [Z]. Beijing: People's Medical Publishing House, 1986.946-947.
  • 8张人伟,中草药,1988年,19卷,5期,7页
  • 9龚运淮,天然有机化合物的1 3C核磁共振化学位移,1986年,157页
  • 10王锦平,中成药研究,1985年,7卷,12期,25页

共引文献154

同被引文献256

引证文献19

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部